Navigation Links
Korean Food and Drug Administration Approval for ActiPatch Achieved
Date:10/16/2007

FREDERICK, Md., Oct. 16 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that the by the Korean Food and Drug Administration has cleared ActiPatch for sale in Korea.

"We have been working closely with our distributor, YoungKwangSa Co., Ltd., to achieve the approval of the Korean F.D.A. Having worked so diligently to obtain the approvals, we are confident that YoungKwangSa is now poised to successfully launch ActiPatch in the Korean market. We expect to ship the initial stock order within the next 15 days," said Andrew Whelan, President of BioElectronics Corporation.

Marshal Nam of YoungKwangSa said "We are pleased to have achieved the clearance from the Korean FDA to begin importing the ActiPatch device. It was a long process and we worked cooperatively with BioElectronics Corporation to obtain the necessary approvals. We are excited to represent ActiPatch in Korea and expect to have a strong business relationship with BioElectronics Corporation for many years."

About YoungKwangSa Co., Ltd.:

Founded in 1971, YoungKwangSa has provided medical professionals in Korea with the most state-of-the art medical devices available. To learn more about YoungKwangSa please visit http://www.actipatch.co.kr.

About BioElectronics:

BioElectronics Corporation is the maker of ActiPatch. ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Brady Corp. acquires Korean counterpart
2. Third Wave seeks approval of Cystic Fibrosis test
3. Kyron wins FDA approval for brain imaging technology
4. SGI receives court approval for bankruptcy motions
5. FDA programs encourage and expedite drug development and approval
6. UW-Stevens Point Professor Receives Patent Approval For New Technology
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. 140-Fold Increase of Protein Achieved in Pichia Fermentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):